Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Real-World Evidence of Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Gloria Iacoboni, MD, Josu Iraola-Truchuelo, Nuria Martinez-Cibrian, MD, Rebeca Bailén, MD, Lucia Lopez Corral, PhD MD, Jose M. Sanchez, MD, Manuel Guerreiro, MD, ANA Carolina Carolina CABALLERO González, Alberto Mussetti, MD, Juan-Manuel Sancho, MD PhD, Rafael Hernani, MD, Carlos Solano, MD PhD, Anna Sureda Balari, MD PhD, Javier Briones, MD PhD, Alejandro Martin Garcia-Sancho, MD PhD, Mi Kwon, MD PhD, Juan Luis Reguera, MD PhD, Pere Barba, MD PhD

Blood (2020) 136 (Supplement 1): 19–21.

https://doi.org/10.1182/blood-2020-136201

Published: 2020

Journal Articles

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic

Alberto Mussetti, MD, Maria Queralt Salas Gay, MD, Maria Condom, MD, Maite Antonio, MD PhD, Cristian Ochoa, Iulia Ivan, David Jiménez Ruiz De La Torre, MD, Gabriela Isabel Sanz-Linares, MD, Belen Ansoleaga, Rocio Parody, MD, Ali Bazarbachi, MD PhD, Anna Sureda Balari, MD PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-138780

Published: 2020

Journal Articles

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-138809

Published: 2020

Journal Articles

Intention-to-Treat Analysis of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Peripheral T-Cell Non-Hodgkin Lymphomas: A Large Italian Single-Center Experience

Nicoletta Cieri, MD PhD, Anna Dodero, MD, Martina Pennisi, MD, Alberto Mussetti, MD, Lucia Farina, Anna Guidetti, MD, Paolo Corradini, MD

Blood (2017) 130 (Supplement 1): 3322.

https://doi.org/10.1182/blood.V130.Suppl_1.3322.3322

Published: 2017

Journal Articles

CD3 Lymphocyte Graft Content and Not Hematopoietic Stem Cell Source Is Associated to Higher Chronic GVHD after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Alberto Mussetti, MD, Chiara De Philippis, MD, Cristiana Carniti, Mariana Bastos Oreiro, MD, Jorge Gayoso, MD, Nicoletta Cieri, MD PhD, Fabio Ciceri, MD, Raffaella Greco, MD, Francesca Patriarca, MD, Jacopo Mariotti, Luca Castagna, MD, Paolo Corradini, MD

Blood (2017) 130 (Supplement 1): 4587.

https://doi.org/10.1182/blood.V130.Suppl_1.4587.4587

Published: 2017

Journal Articles

Rituximab Dose Adjusted EPOCH Improves Progression-Free Survival of Patients Affected By Diffuse Large Cell Lymphomas with Double Expression of MYC and BCL2 Proteins

Anna Dodero, MD, Anna Guidetti, MD, Alessandra Tucci, MD, Alessio Pellegrinelli, Antonello Cabras, MD, Liliana Franca Devizzi, MD, Lucia Farina, Luca Pappalettera, MD, Alberto Mussetti, MD, Maria Chiara Di Chio, MD, Rosa Jessica, MD, Martina Soldarini, MD, Angela Passi, MD, Paola Matteucci, MD, Stefano A. Pileri, Giuseppe Rossi, MD, Paolo Corradini, MD

Blood (2017) 130 (Supplement 1): 2844.

https://doi.org/10.1182/blood.V130.Suppl_1.2844.2844

Published: 2017

Journal Articles

Final Results of a Multicenter Prospective Phase II Trial of Allogeneic Transplantation for Relapsed/Refractory CD20+ B-Cell Lymphomas: Effect of Rituximab on Graft-Versus-Host Disease-Free/Relapse-Free Survival (GRFS)

Anna Dodero, Francesca Patriarca, Giuseppe Milone, MD, Barbara Sarina, MD, Rosalba Miceli, Anna Paola Iori, Francesco Barretta, Elisabetta Terruzzi, MD, Alberto Mussetti, MD, Massimo Pini, MD, Alberto Bosi, Alida Dominietto, MD, Nicola Cascavilla, MD, Francesco Onida, MD, Franco Narni, Lucia Farina, MD PhD, Alessandro Rambaldi, MD, Paolo Corradini

Blood (2016) 128 (22): 3473.

https://doi.org/10.1182/blood.V128.22.3473.3473

Published: 2016

Journal Articles

Unmanipulated Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post Transplant Cyclophosphamide Anti-Gvhd Prophylaxis

Luca Castagna, MD, Alberto Mussetti, MD, Raynier Devillier, MD PhD, Alida Dominietto, MD, Magda Marcatti, MD, Giuseppe Milone, MD, Francesco Maura, MD, Benedetto Bruno, MD PhD, Sabine Furst, MD, Didier Blaise, MD PhD, Paolo Corradini, MD, Vittorio Montefusco, MD

Blood (2016) 128 (22): 3475.

https://doi.org/10.1182/blood.V128.22.3475.3475

Published: 2016

Journal Articles

Role of Cell Source and Graft Composition in Haploidentical Transplantation Using Post-Transplant Cyclophosphamide

Alberto Mussetti, MD, Chiara De Philippis, MD, Cristiana Carniti, PhD, Mariana Bastos Oreiro, MD, Jorge Gayoso, MD, Nicoletta Cieri, MD PhD, Jacopo Peccatori, MD, Paolo Corradini, MD

Blood (2016) 128 (22): 4664.

https://doi.org/10.1182/blood.V128.22.4664.4664

Published: 2016

Journal Articles

Late Relapse in Hodgkin Lymphoma (HL): A Retrospective Analysis of Patients Enrolled on Clinical Trials at the Istituto Nazionale Tumori of Milan (INT-MI)

Simonetta Viviani, MD, Alberto Mussetti, MD, Oreste Di Bartolo, MD, Antonello Cabras, MD, Pinuccia Valagussa, Statistician, Gianni Bonadonna, MD, Alessandro M. Gianni, MD, Paolo Corradini, MD

Blood (2015) 126 (23): 2697.

https://doi.org/10.1182/blood.V126.23.2697.2697

Published: 2015

Journal Articles

Survival after T-Cell Replete Haploidentical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor (MUD) Transplant for Lymphoid Malignancies

Alberto Mussetti, MD, Abraham Sebastian Kanate, MD, Mohamed A Kharfan-Dabaja, MD, Kwang Woo Ahn, PhD, Alyssa DiGilio, MS, Stefan O Ciurea, MD, Philippe Armand, MD PhD, Rachel B. Salit, MD, Timothy S. Fenske, MD MS, Sonali M. Smith, MD, Anna Sureda, MD PhD, Javier Bolanos-Meade, MD, Mehdi Hamadani, MD

Blood (2015) 126 (23): 194.

https://doi.org/10.1182/blood.V126.23.194.194

Published: 2015

NARROW

Real-World Evidence of Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic

Prospective Multicentric Observational Study of COVID19 in Oncohematological Patients in the Catalonia Region: The Opposite Effect of Steroids on Survival

Intention-to-Treat Analysis of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Peripheral T-Cell Non-Hodgkin Lymphomas: A Large Italian Single-Center Experience

CD3 Lymphocyte Graft Content and Not Hematopoietic Stem Cell Source Is Associated to Higher Chronic GVHD after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Rituximab Dose Adjusted EPOCH Improves Progression-Free Survival of Patients Affected By Diffuse Large Cell Lymphomas with Double Expression of MYC and BCL2 Proteins

Final Results of a Multicenter Prospective Phase II Trial of Allogeneic Transplantation for Relapsed/Refractory CD20+ B-Cell Lymphomas: Effect of Rituximab on Graft-Versus-Host Disease-Free/Relapse-Free Survival (GRFS)

Unmanipulated Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post Transplant Cyclophosphamide Anti-Gvhd Prophylaxis

Role of Cell Source and Graft Composition in Haploidentical Transplantation Using Post-Transplant Cyclophosphamide

Late Relapse in Hodgkin Lymphoma (HL): A Retrospective Analysis of Patients Enrolled on Clinical Trials at the Istituto Nazionale Tumori of Milan (INT-MI)

Survival after T-Cell Replete Haploidentical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor (MUD) Transplant for Lymphoid Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only